Anastrozole Hydrochloride is an aromatase inhibitor of the triazole class, primarily indicated for the treatment of hormone receptor-positive breast cancer in postmenopausal women by reducing estrogen… Read more
Anastrozole Hydrochloride is an aromatase inhibitor of the triazole class, primarily indicated for the treatment of hormone receptor-positive breast cancer in postmenopausal women by reducing estrogen production. This category features high-quality reference standards for Anastrozole Hydrochloride, alongside a comprehensive selection of its pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope labelled compounds. These materials are essential for pharmaceutical laboratories performing impurity profiling, method validation, and rigorous quality control testing. By providing consistent standards for analytical applications, these compounds enable researchers to accurately identify and quantify degradation products and potential synthesis by-products during pharmaceutical development and stability studies. Utilizing precise reference materials ensures compliance with regulatory requirements and supports the integrity of quantitative analysis in complex biological or chemical matrices.